WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 531166
Description: M&B 5885 is a biaoctive chemical.
MedKoo Cat#: 531166
Name: M&B 5885
Chemical Formula: C17H31NO4S2
Exact Mass: 377.1694
Molecular Weight: 377.558
Elemental Analysis: C, 54.08; H, 8.28; N, 3.71; O, 16.95; S, 16.98
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: M&B 5885
IUPAC/Chemical Name: m-Toluidine, alpha-(methylthio)-4-(octyloxy)-, methanesulfonate
InChi Key: DOTQBYPYRCLPRT-UHFFFAOYSA-N
InChi Code: InChI=1S/C16H27NOS.CH4O3S/c1-3-4-5-6-7-8-11-18-16-10-9-15(17)12-14(16)13-19-2;1-5(2,3)4/h9-10,12H,3-8,11,13,17H2,1-2H3;1H3,(H,2,3,4)
SMILES Code: NC1=CC=C(OCCCCCCCC)C(CSC)=C1.CS(=O)(O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 377.558 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Moine P, Mueller SW, Schoen JA, Rothchild KB, Fish DN. Pharmacokinetic and Pharmacodynamic Evaluation of a Weight-Based Dosing Regimen of Cefoxitin for Perioperative Surgical Prophylaxis in Obese and Morbidly Obese Patients. Antimicrob Agents Chemother. 2016 Sep 23;60(10):5885-93. doi: 10.1128/AAC.00585-16. Print 2016 Oct. PubMed PMID: 27458209; PubMed Central PMCID: PMC5038324.
2: Wu S, Guo Z, Hopkins CD, Wei N, Chu E, Wipf P, Schmitz JC. Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells. Oncotarget. 2015 Dec 1;6(38):40866-79. doi: 10.18632/oncotarget.5885. PubMed PMID: 26506423; PubMed Central PMCID: PMC4747374.
3: McPherson JP, Brown GA, Goldenberg GJ. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus. Cancer Res. 1993 Dec 15;53(24):5885-9. PubMed PMID: 8261398.
4: Kumar N, Blumenthal R, Henkart M, Weinstein JN, Klausner RD. Aggregation and calcium-induced fusion of phosphatidylcholine vesicle-tubulin complexes. J Biol Chem. 1982 Dec 25;257(24):15137-44. PubMed PMID: 6897406.